In a retrospective analysis of 107 patients, Wallwiener et al. revealed that the overall accuracy between HER2 expression in CTC, PIP HER2 status and metastatic tumor tissue HER2 status was 69% and 74%, respectively [16]. Here, ERBB2 is linked to metastatic neoplasm.